Doxorubicin-cisplatin-vinblastine combination chemotherapy of advanced endometrial carcinoma: A Southwest Oncology Group study
- 18 February 1987
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 26 (2), 193-201
- https://doi.org/10.1016/0090-8258(87)90273-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Treatment of recurent endometrial adenocarcinoma with a combination of doxorubicin and cisplatinAmerican Journal of Obstetrics and Gynecology, 1984
- In vitro chemotheraphy testing of gynecologic tumors: Basis for planning therapy?American Journal of Obstetrics and Gynecology, 1983
- Chemotherapy of ovarian cancer directed by the human tumor stem cell assayCancer Chemotherapy and Pharmacology, 1981
- IN-VITRO CLONOGENIC ASSAY FOR PREDICTING RESPONSE OF OVARIAN CANCER TO CHEMOTHERAPYThe Lancet, 1980
- PHASE-II TRIAL OF ADRIAMYCIN IN THE TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - GYNECOLOGIC ONCOLOGY GROUP-STUDY1979
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978
- COMPARISON OF ADRIAMYCIN WITH CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED ENDOMETRIAL CANCER1978
- Primary Bioassay of Human Tumor Stem CellsScience, 1977
- Doxorubicin-cyclophosphamide: Effective chemotherapy for advanced endometrial adenocarcinomaAmerican Journal of Obstetrics and Gynecology, 1977
- Nonhormonal chemotherapy of endometrial adenocarcinoma: A reviewCancer, 1974